Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-Integrins for the Treatment of Inflammatory Bowel Disease: Current Evidence and Perspectives
John Gubatan, Kian Keyashian, Samuel J. S. Rubin, et al.
Clinical and Experimental Gastroenterology (2021) Vol. Volume 14, pp. 333-342
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Targeting integrin pathways: mechanisms and advances in therapy
Xiaocong Pang, Xu He, Zhiwei Qiu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 463
Treatment of Inflammatory Bowel Disease: A Comprehensive Review
Zhaobei Cai, Shu Wang, Jiannan Li
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 407
Integrin signaling in cancer: bidirectional mechanisms and therapeutic opportunities
Siyi Li, Chibuzo Sampson, Changhao Liu, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 53
The NF-κB signaling system in the immunopathogenesis of inflammatory bowel disease
Tapas Mukherjee, Naveen Kumar, M. L. Chawla, et al.
Science Signaling (2024) Vol. 17, Iss. 818
Closed Access | Times Cited: 38
Contextual AI models for single-cell protein biology
Michelle M. Li, Yepeng Huang, Marissa Sumathipala, et al.
Nature Methods (2024) Vol. 21, Iss. 8, pp. 1546-1557
Open Access | Times Cited: 16
Host-microbe multi-omics and succinotype profiling have prognostic value for future relapse in patients with inflammatory bowel disease
Janet O’Sullivan, Shriram Patel, Gabriel E. Leventhal, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
New and Emerging Treatments for Inflammatory Bowel Disease
Masaaki Higashiyama, Ryota Hokari
Digestion (2022) Vol. 104, Iss. 1, pp. 74-81
Open Access | Times Cited: 69
Immune-mediated inflammatory diseases: Common and different pathogenic and clinical features
Giovanni Monteleone, A. Moscardelli, Alice Colella, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 10, pp. 103410-103410
Open Access | Times Cited: 33
Pathological mechanism and targeted drugs of ulcerative colitis: A review
Meitong Guo, Xiaoyan Wang
Medicine (2023) Vol. 102, Iss. 37, pp. e35020-e35020
Open Access | Times Cited: 26
A Narrative Review of Cytokine Networks: Pathophysiological and Therapeutic Implications for Inflammatory Bowel Disease Pathogenesis
Marek Vébr, Renata Pomahačová, Josef Sýkora, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3229-3229
Open Access | Times Cited: 24
Updates on the management of inflammatory bowel disease from periconception to pregnancy and lactation
Ole Haagen Nielsen, John Gubatan, Kaija‐Leena Kolho, et al.
The Lancet (2024) Vol. 403, Iss. 10433, pp. 1291-1303
Closed Access | Times Cited: 15
Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options
Eguzkiñe Díez-Martín, Leidi Hernández-Suárez, Carmen Muñoz-Villafranca, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7062-7062
Open Access | Times Cited: 11
Immunogenicity and Loss of Effectiveness of Biologic Therapy for Inflammatory Bowel Disease Patients Due to Anti-Drug Antibody Development
Tsvetelina Velikova, Metodija Sekulovski, Monika Peshevska-Sekulovska
Antibodies (2024) Vol. 13, Iss. 1, pp. 16-16
Open Access | Times Cited: 10
Ulcerative colitis: molecular insights and intervention therapy
Yuqing Liang, Yang Li, Chehao Lee, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 9
Pharmacological Therapy in Inflammatory Bowel Diseases: A Narrative Review of the Past 90 Years
Marcello Imbrizi, Fernando Magro, Cláudio Saddy Rodrigues Coy
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1272-1272
Open Access | Times Cited: 18
From the updated landscape of the emerging biologics for IBDs treatment to the new delivery systems
Jiaojiao Yang, Dingwei Li, Mengjiao Zhang, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 568-591
Closed Access | Times Cited: 16
Integrins regulation of wound healing processes: insights for chronic skin wound therapeutics
Yu Dong, Zhaoyu Lu, Fengsong Nie, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 5
Carotegrast Methyl: First Approval
Sohita Dhillon
Drugs (2022) Vol. 82, Iss. 9, pp. 1011-1016
Open Access | Times Cited: 20
Placebo-Controlled Trials in the Management of Crohn’s Disease: An Umbrella Review of Meta-Analyses
Richard Silva, José Nunes de Azevedo, Jorge Machado, et al.
Medical Sciences (2025) Vol. 13, Iss. 1, pp. 12-12
Open Access
Quantitative proteomic studies of the intestinal mucosa provide new insights into the molecular mechanism of ulcerative colitis
Yandong Guo, Dahal Pabitra, Lei Pan, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Advances in Gut Microbiota Functions in Inflammatory Bowel Disease: Dysbiosis, Management, Cytotoxicity Assessment, and Therapeutic Perspectives
Ivan Kushkevych, M Dvořáková, Đani Đorđević, et al.
Computational and Structural Biotechnology Journal (2025) Vol. 27, pp. 851-868
Open Access
VCAM-1 as a common biomarker in inflammatory bowel disease and colorectal cancer: unveiling the dual anti-inflammatory and anti-cancer capacities of anti-VCAM-1 therapies
Jessica R. Pickett, Yuao Wu, Hang T. Ta
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 2
Open Access
Drug Repurposing to Inhibit Oncostatin M in Crohn’s Disease
Faranak Bahramimehr, Axel Guthart, Sandra Kurz, et al.
Molecules (2025) Vol. 30, Iss. 9, pp. 1897-1897
Open Access
The Role of Neutrophils in Spondyloarthritis: A Journey across the Spectrum of Disease Manifestations
Lavinia Agra Coletto, Chiara Rizzo, Giuliana Guggino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4108-4108
Open Access | Times Cited: 10
Inflammatory Bowel Disease: Pathophysiology, Treatment, and Disease Modeling
Jiryeon Jang, Sehoon Jeong
BioChip Journal (2023) Vol. 17, Iss. 4, pp. 403-430
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top